Using CANTAB to examine the potential synergistic effects of a combination of omega-3 fatty acids, c
Dr Rebecca Power, Postdoctoral Researcher at the Nutrition Research Centre Ireland, shared the role that CANTAB played in her latest publication: Targeted Nutritional Intervention for Patients with Mild Cognitive Impairment: The Cognitive impAiRmEnt Study (CARES) Trial 1
CANTAB Research Grant assists research into defining cognitive phenotypes in individuals with CNVs a
Ciara Molloy recently spoke to us about the impact that receiving one of the three 2020 CANTAB Research Grant prizes will have on her research: ‘The impact of rare copy number variants on cognition: Defining cognitive phenotypes in individuals with CNVs associated with neurodevelopmental and neuropsychiatric disorders.’
2020 CANTAB Research Grant supports research into combined dexmedetomidine / ketamine nasal spray fo
The winner of one of the three 2020 CANTAB Research Grant prizes, Dr Amie Hayley, Swinburne University of Technology explains the impact CANTAB will have on her research: Combined dexmedetomidine/ketamine nasal spray for analgesia: a pilot feasibility and efficacy trial.
Dr Simone De Luca recently received the 2020 CANTAB Research Grant primary award for her project: “New ways to assess vascular cognitive impairment and dementia (VCID) in chronic lung disease”. We spoke to her about the impact winning would have on her research.
Using CANTAB to study the relationships between executive function, eating behavior and preoperative
PhD candidate Gro Walø-Syversen of Oslo University Hospital, shared the role that CANTAB played in her latest publication: Executive Function, Eating Behavior, and Preoperative Weight Loss in Bariatric Surgery Candidates: An Observational Study.
Alexander Friend shares the role CANTAB played in the research he conducted on cognitive impairment at high-altitude while at The University of Birmingham.
We caught up with Jana Thomas of Radboud University Medical Centre to find out more about the bidirectional relationship between poor sleep and Alzheimer’s disease.
Examination of the neural basis of psychotic-like experiences in adolescence during processing of em
We caught up with Dr Evan Papanastasiou from King's College London to find out why he chose CANTAB to examine the neural basis of psychotic-like experiences in adolescence during processing of emotional faces.
Despite chemotherapy-associated cognitive impairment (CACI, aka chemobrain) affecting 75% of all cancer survivors, little is understood about the mechanisms underlying the disorder. In efforts to address this research gap, Prof Alexandre Chan from the University of California, Irvine used CANTAB to conduct an evaluation of DNA Methyltransferase 1 (DNMT1) Single Nucleotide Polymorphisms and Chemotherapy-Associated Cognitive Impairment. Read on to find out the results.
We caught up with Jacob Crouse from the University of Sydney’s Brain and Mind Centre to discuss his research into key factors that underpin mental health disorders in young people, with a view to improving outcomes.
PSYSCAN is a global project, which aims to develop a neuroimaging-based tool that will help healthcare professionals to address key clinical issues for patients with psychotic disorders. We caught up with study coordinator – Aimée Westerveld – to find out more about the role of CANTAB in the project.
What is the impact of stress and environment on executive function and motivation for primary school
We caught up with Toby Bartle, Registered Psychologist and PhD Candidate at James Cook University, to find out why he chose CANTAB when looking at the impact of stress and environment on executive function and motivation for primary school children.
We caught up with University of Ulster researcher, Kyle Wallace, to find out why he chose CANTAB to investigate the links between cognitive function, hydration status and martial arts.
Dr Qiang Luo, Associate Principal Investigator at the Institute of Science and Technology for Brain-inspired Intelligence - Fudan University, shared the role that CANTAB played in his latest publication: Adolescent binge drinking disrupts normal trajectories for brain functional organization and personality maturation.
Senior Psychology Technician at Teesside University, Nicole Beddard, shared her experience of administrating a CANTAB departmental licence.
Cassandra Wannan, final year PhD student at the University of Melbourne, shared the role that CANTAB played in her latest publication: Hippocampal subfields and visuospatial associative memory across stages of schizophrenia-spectrum disorder.
We caught up with researchers from the Division of Neuroscience and Experimental Psychology, University of Manchester to discuss the role that CANTAB plays in their cutting-edge neuroimaging study.
The Salud Ambiental Montevideo cohort is characterised by several social-environmental factors, including exposure to metals and cognitive performance. We caught up with Seth Frndak from the University of Buffalo to talk through CANTAB’s role in this epidemiological study.
TwinsUK has been using CANTAB for the last 10 years to enable their multi-modal, longitudinal research into typical and pathological ageing. We caught up with the Project Coordinator, Taha Bhatti, to discuss the cohort’s experience of completing the tasks, and transitioning to web-based delivery.
With more than two million participants, Dementias Platform UK is a national effort to make real strides in tackling dementia. Leona Wolters from the initiative shared with us the vital role that CANTAB plays in this large-scale cohort study.
We caught up with psychologist, Lara Draghi, to discuss the value of using CANTAB to assess cognitive function in patients with rare neurological disorders.
Researchers at the University of Newcastle, Australia are developing a screening tool of social cognitive abilities for individuals with schizophrenia spectrum disorder or acquired brain injury. Read on to find out how CANTAB is supporting this effort.
We caught up with Professor Marco Bonetti to discover whether economic models could be applied in mental health research to better explain how OCD patients make decisions under risk.
We’re delighted to announce that CANTAB Connect – our cognitive research platform validated by use in over 2,100 published papers - is being used by Europe’s largest university clinic, Charité – Universitätsmedizin Berlin, for the assessment of long-term cognitive outcomes in clinical studies on patients scheduled for elective surgery.
We caught up with Mohammad Ali Salehinejad to discuss the results of his latest publication entitled: Cognitive control dysfunction in emotion dysregulation and psychopathology of major depression (MD): Evidence from transcranial brain stimulation of the dorsolateral prefrontal cortex (DLPFC).
Professor Eirini Flouri spoke to us about why they chose CANTAB to investigate children’s spatial working memory in a large, epidemiological study.
Dr Thomas Johansen from the Norwegian National Advisory Unit on Occupational Rehabilitation talked us through why he chose CANTAB to investgate whether improving cognitive function during occupational rehabilitation improves return to work.
We caught up with Dr Arvin Haghighatfard to discuss why he chose CANTAB to investigate the effects of neuregulin 1 on executive dysfunction in autism spectrum disorder.
We caught up with Dr Evangelos Papanastasiou to discuss his latest publication, and the next steps for improving the early diagnosis of psychotic illness.